Patent №
US 11,640,846
Granted
2023-05-02
Filed 2021
Owner
FRESENIUS MEDICAL CARE HOLDINGS, INC.
Lab
—
AI components
2
planning · hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
17162030
Systems, methods, and/or apparatuses may be operative to perform a dialysis process that includes a displacer infusion process. In one embodiment, a method for determining a displacer compound may include constructing a plurality of target protein quantitative structure-activity relationship (QSAR) models, one for each of the plurality of binding sites, analyzing a set of candidate compounds using the plurality of QSAR models to determine a set of at least one potential compound with an affinity for binding to each of the plurality of binding sites, and selecting at least one displacer compound from the set of at least one potential compound. Other embodiments are described.
AI classification
Ownership
FRESENIUS MEDICAL CARE HOLDINGS, INC.
assignment · 563730518
Assignors
TAO, XIA, MAHESHWARI, VAIBHAV, KOTANKO, PETER, THIJSSEN, STEPHAN, GROBE, NADJA
On an employer assignment, the assignors are typically the inventors.